×

Dosage forms and related therapies

  • US 9,339,479 B2
  • Filed: 12/17/2014
  • Issued: 05/17/2016
  • Est. Priority Date: 08/20/2002
  • Status: Active Grant
First Claim
Patent Images

1. A composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a succinic acid addition salt of triethylenetetramine.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×